Attention deficit hyperactivity disorder (ADHD) is one of the most common neurobehavioral disorders in children (
Attention-deficit, 2011). The ADHD symptoms include hyperactivity, inattention, and impulsivity (
Attention-deficit, 2011). The exact etiology of developing ADHD is still unknown, but environmental and genetic factors are proposed to be involved in its development (
Biederman, 2005). This disorder is also associated with depression (
Elia et al., 2008). This disorder in children may lead to lower educational and occupational levels, personality disorders, depression, delinquency, addiction, and marital problems in adulthood (
Klein et al., 2012,
Mannuzza et al., 1993). The prevalence of ADHD in the world is estimated to be 5.29% (
Polanczyk et al., 2007). It is also proposed that 16.3% of the 6-year-old Yazdi children have ADHD (
Akhavan Karbasi et al., 2008).
Weight and blood pressure (BP) are factors associated with ADHD (
Byrd et al., 2013,
Wilens et al., 2005). In a study on a large number of German teenagers, Meyer et al. found a significant relationship between low BP and ADHD symptoms (
Meyer et al., 2017). Several studies examined the relationship between ADHD and obesity (
Azadbakht and Esmaillzadeh, 2012,
Fliers et al., 2013). A systematic review and meta-analysis also showed that ADHD had a significant relationship with overweight and obesity. The study also found that prevalence of obesity in children with ADHD was about 40% higher than the healthy children. Moreover, the prevalence of obesity in adults with ADHD was 70% higher than the normal population (
Cortese et al., 2015).
Different nutritional factors are effective on ADHD including food and artificial colors, artificial sweeteners and sugars, amino acids (tryptophan, phenylalanine and tyrosine), vitamins and minerals, essential fatty acids, and restrictive diets (
Heilskov Rytter et al., 2015). Dietary Approaches to Stop Hypertension (DASH) is a diet rich in fruits, vegetables, whole grains, low-fat dairy products, cereals, and low-fat meals. It also contains low levels of sodium, saturated and total fat, as well as high levels of calcium, magnesium, potassium, and vitamin C (
Sacks et al., 2001). This is a low-glycemic and low-energy diet effective in managing the BP (
Sacks et al., 2001). Recent studies showed that this diet, affects not only BP (
Saneei et al., 2014), but also other diseases such as type 2 diabetes (
Shirani et al., 2013), cardiovascular disease (
Shirani et al., 2013), lipid profile, and glucose tolerance in pregnancy diabetes (
Asemi et al., 2013).
The DASH diet lowers BP in people with hypertension, but it does not affect normal BP (
Saneei et al., 2014). This diet also controls weight and causes weight loss in adults with overweight and obesity (
Soltani et al., 2016).
The prevalence of ADHD is high in the world and in Iran, especially Yazd. Furthermore, no study has ever investigated the effect of a healthy diet on weight and BP in children with ADHD. So, the present controlled clinical trial evaluated the effect of DASH diet on weight and BP in children with ADHD.
Materials and Methods
Study design and participants: A total of 253 children within the age range of 6 to 12 years were diagnosed with ADHD according to the Conner’s Teacher's Questionnaire and DSM-4 criteria by a specialist. Of these, 27 did not meet the inclusion criteria and 140 were not willing to participate in the study. Finally, 86 children entered the study (
Figure 1). The exclusion criteria were having other neurological diseases associated with ADHD, low IQ (less than 70), prematurity at birth, sudden dietary changes or non-compliance with the prescriptive diet, and reluctance to continue to participate in the study with any reason, being an adopted child, and using drugs.
This randomized clinical trial was conducted in Yazd, Iran. A total of 86 children were randomly divided into two groups of DASH diet and control diet by simple random sampling using SPSS software. The intervention lasted 12 weeks. The participants' anthropometric indices, BP measurements, physical activity, and dietary compliance were evaluated each month. This process was conducted every month until the end of the third month of follow-up.
Diets: The required energy intake was calculated for each child by the researcher using the American Institute of Food and Drug Administration's Medical Institute formula based on their weight, height, age, and physical activity level determined by a questionnaire at the beginning of the study (
Gidding et al., 2006). The children were randomly assigned into two diet groups: DASH diet and control diet. DASH diet was given to participants according to macronutrient ratio of 50-60% carbohydrate, 25-30% fat, and 15-20% protein for the intervention group along with a succession of food groups. The DASH diet contains high amounts of whole grains, fruits, vegetables and low-fat dairy products, cereals, as well as low amounts of saturated fats, cholesterol, refined grains, sweets, and red meat (
Sacks et al., 2001). In this diet, calcium, potassium, and magnesium contents of DASH diet are higher than the recommendations provided by the US Department of Agriculture. Control group diet was similar to the DASH diet with regard to the macronutrient contents: 60-50% carbohydrates, 25-30% fat, and 15-20% protein, which was similar to the usual Iranian diet (
Azadbakht et al., 2005).
Table 1 shows the food groups of the DASH diet compared to the control diet for a 1500 kcal diet.
Measurements: The participants' weight was measured using the Omron BF511 (Omron Inc. Osaka, Japan) body analyzer with a precision of 0.1 kg, while people stand in the middle of the balance in light clothing. Height was also measured in cm in standing position by a fixed height gauge. Body mass index (BMI) was measured by dividing the weight (in kilograms) by height (in squared m). To determine the waist circumference (WC), an elastic plastic meter was applied with a precision of 0.5 cm. The WC was measured at the distance between the three iliac crests and the lowest rib in standing position. To measure the hip circumference, the largest hip circumference was measured with a precision of 0.5 cm. The percentage of body fat and body muscle percentage were also measured using Omron BF511 (Omron Inc. Osaka, Japan) body analyzer. All anthropometric measurements were performed by a trained nutritionist. Anthropometric measurements were performed for each person three times and the values were recorded at least twice for each person.
BP was also measured three times using a standard mercury pressure gauge with a 5-minute interval.
For evaluation of the dietary intakes, the 24-hour recall was initially administered and the three-day dietary records including two workdays and a weekend day were used before each visit, which were completed by parents. Dietary records were analyzed for their energy and nutrient content using Nutritionist-IV software (version 3.5.2, Axxya Systems, Redmond, Washington, USA) modified for Iranian food items. Parents were also asked to record their children’s physical activity before each visit. Physical activity information was converted to metabolic equivalent-hour/day (Met-h/day) using the MET intensity, type, and duration of each activity.
Data analysis: The normal distribution of quantitative data was investigated using Kolmogrov-Smirnov statistical test. All data had normal distribution. Independent samples t-test was used to compare the quantitative variables between the intervention and the control groups. Paired samples t-test was used to evaluate the within group changes in the two groups. The age and gender comparisons for the quantitative variables were done using analysis of covariance (ANCOVA) by bonferroni correction. Data were reported in mean ± standard error (SE). P-values of less than 0.05 (2-tailed) were considered as statistically significant. Statistical analyses were performed using statistical package for social sciences software version 25 (IBM SPSS, Tokyo, Japan).
Ethical considerations: The study protocol was approved by Ethics Committee of Faculty of Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran (Ethics code: IR.SSU.SPH.REC.1395.106). The study was also registered in the Iranian Registry of Clinical Trials on January 8, 2018 (IRCT, www.irct.ir, registration ID: IRCT20130223012571N6). The children's parents were provided with verbal and written information about the study goals. They were also asked to sign informed consent forms before participating in the study.
Results
After 12 weeks, three children were removed from DASH group (2 children due to lack of motivation to continue the study and one due to starting the medication use). In the control group, three children were excluded (2 children due to lack of motivation and one child due to immigration from Yazd city). A total of 80 participants (40 in each group) completed the study (
Figure 1).
The means (± SE) for age, weight, and height at the beginning of the study were 8.67 ± 0.25, 28.90 ± 1.38 kg, and 129.55 ± 1.44 cm in DASH group and 8.41 ± 0.24, 27.39 ± 1.17 kg, and 128.44 ± 1.72 cm in the control group, respectively. No difference was observed between the study groups based on the baseline data (
P > 0.05).
The average consumption of nutrient intake based on a 3-day diet and physical activity during the intervention period are presented in
Table 2. Based on the 24-hour food intake, the fat, dietary fiber, vitamin C, and potassium groups increased significantly in DASH group. Moreover, a significant increase was observed in energy, fat, carbohydrate, and calcium intakes in control group. No significant difference was seen in dietary intake between DASH group and control at the beginning of the study. However, a significant difference was found in the mean change between the beginning and end of the study regarding the vitamin C intake (
P = 0.002) and dietary fiber (
P < 0.001) between DASH and control groups.
At the beginning and end of the study, no significant difference was reported in physical activity between DASH group and control group. Furthermore, no significant difference was found between the mean changes in physical activity between the two groups (
P = 0.35).
Table 3 shows the body composition indices before and after the intervention period in the intervention group. The results revealed that weight, BMI, middle arm muscle circumference (MUAC), and muscle mass significantly increased, while the body fat percent decreased significantly (
P = 0.02). The wrists' diameter also marginally increased (
P = 0.06), but the waist, hip, and neck circumferences did not increase significantly (
P = 0.37,
P = 0.36, and
P = 0.27, respectively). In the control group, weight, height, body mass index, waist circumference, hip circumference, wrist circumference, MUAC, and body muscle percent increased significantly. The neck circumference marginally increased (
P = 0.05), but body fat percentage did not decrease significantly (
P = 0.63). No significant difference was observed in body composition before and after the intervention period. The mean difference was not significant before and after the intervention between the DASH and control groups.
Table 3 represents the systolic BP (SBP) and diastolic BP (DBP) before and after the intervention period in DASH and control groups. No significant difference was observed in the SBP and DBP at baseline between the two groups. According to these data, systolic and diastolic BP increased significantly in the DASH group (
P < 0.05). In the control group, the SBP marginally increased (
P < 0.05) and the DBP did not increase significantly (
P > 0.05). No significant difference was observed at the end of the study in SBP (
P > 0.05), but a significant difference was found at the end of study in DBP between study groups (
P = 0.02). The mean change before and after the study between the two groups of DASH and control was not different in SBP (
P = 0.32); whereas, the change in the DBP was significantly different (
P = 0.02).
Table 4 shows the mean changes in body composition and BP indices of the DASH and the control groups after adjusting for age and gender. The mean changes in body composition and BP were not significant between the intervention and control groups. The results revealed that the mean changes in SBP were not different between the two groups after adjusting for age and gender. However, the DBP increased significantly in the DASH group compared to the control group (
P < 0.05).
Figure 2 represents the effect of DASH diet compared to the control diet on SBP (A), DBP (B), body fat percent (C), and BMI (D) according to the study visits after adjusting for age and gender. A significant difference was found in mean difference of DBP only in the last month of the study. However, no significant difference was seen in other visits. Increased trend of SBP and BMI as well as reduction of body fat percentage were not significant.